Bloomberg report.The European Medicines Agency said it is safe and effective and the benefits outweigh the risks.However, can't completely rule out a link between the vaccine and blood clots, and will investigate further, it further said.SomEuropean countries said they would not use the vaccine after several reports emerged of blood clots and brain hemorrhages in people who had received the vaccine.Following this, the EMA reviewed case reports from Germany and Norway, among others, to determine whether the problems were caused by the vaccine or whether the timing was a coincidence.
They also compared the patients’ medical profiles, seeking similarities that may point to certain people being at higher risk of clots.While governments said.